Stem-cell transplants show limited benefit for double-hit lymphoma patients in remission
Monday, May 15, 2017 - 13:01
in Health & Medicine
Patients with double hit lymphoma (DHL) who undergo autologous stem-cell transplantation (autoSCT) after achieving remission are not more likely to remain in remission or live longer than patients who do not undergo autoSCT, according to a new analysis.